Infliximab as first-line therapy in severe pediatric Crohn disease

Lissy de Ridder, Marc A. Benninga, Jan A. J. M. Taminiau, Daniël W. Hommes

Research output: Contribution to journal › Article › Academic › peer-review

21 Citations (Scopus)

Original language	English
Pages (from-to)	388-390
Journal	Journal of pediatric gastroenterology and nutrition
Volume	43
Issue number	3
DOIs	https://doi.org/10.1097/01.mpg.0000226369.31956.bf
Publication status	Published - 2006

Access to Document

@article{6f116c514be941e5ab5f8e2cb779d29c,

title = "Infliximab as first-line therapy in severe pediatric Crohn disease",

author = "{de Ridder}, Lissy and Benninga, {Marc A.} and Taminiau, {Jan A. J. M.} and Hommes, {Dani{\"e}l W.}",

year = "2006",

doi = "https://doi.org/10.1097/01.mpg.0000226369.31956.bf",

language = "English",

volume = "43",

pages = "388--390",

journal = "Journal of pediatric gastroenterology and nutrition",

issn = "0277-2116",

publisher = "Lippincott Williams and Wilkins",

number = "3",

}

TY - JOUR

T1 - Infliximab as first-line therapy in severe pediatric Crohn disease

AU - de Ridder, Lissy

AU - Benninga, Marc A.

AU - Taminiau, Jan A. J. M.

AU - Hommes, Daniël W.

PY - 2006

Y1 - 2006

U2 - https://doi.org/10.1097/01.mpg.0000226369.31956.bf

DO - https://doi.org/10.1097/01.mpg.0000226369.31956.bf

M3 - Article

C2 - 16954965

SN - 0277-2116

VL - 43

SP - 388

EP - 390

JO - Journal of pediatric gastroenterology and nutrition

JF - Journal of pediatric gastroenterology and nutrition

IS - 3

ER -